Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam
· Delayed Price · Currency is VND 58,300
+200 (0.34%)
At close: Apr 28, 2026
HNX:DP3 Revenue
Central Pharmaceutical Joint Stock Company No3 had revenue of 134.98B VND in the quarter ending March 31, 2026, with 46.87% growth. This brings the company's revenue in the last twelve months to 481.09B, up 18.57% year-over-year. In the year 2025, Central Pharmaceutical Joint Stock Company No3 had annual revenue of 438.01B with 4.92% growth.
Revenue (ttm)
481.09B
Revenue Growth
+18.57%
P/S Ratio
2.61
Revenue / Employee
n/a
Employees
n/a
Market Cap
1,253.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 438.01B | 20.52B | 4.92% |
| Dec 31, 2024 | 417.49B | 7.75B | 1.89% |
| Jan 1, 2024 | 409.73B | -75.34B | -15.53% |
| Dec 31, 2022 | 485.07B | 104.00B | 27.29% |
| Dec 31, 2021 | 381.08B | -14.64B | -3.70% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| Vidipha Central Pharmaceutical JSC | 971.25B |
| OPC Pharmaceutical JSC | 1,122.99B |
| Domesco Medical Import - Export Joint-Stock | 2,117.78B |
| Cuu Long Pharmaceutical JSC | 1,321.59B |
| Traphaco JSC | 2,657.21B |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1,865.38B |
| Mediplantex National Pharmaceutical JSC | 366.83B |